These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1477183)
1. Transforming growth factor-beta inhibits human T-cell proliferation through multiple targets. Fox FE; Capocasale RJ; Ford HC; Lamb RJ; Moore JS; Nowell PC Lymphokine Cytokine Res; 1992 Dec; 11(6):299-305. PubMed ID: 1477183 [TBL] [Abstract][Full Text] [Related]
2. Effect of transforming growth factor-beta on early and late activation events in human T cells. Ahuja SS; Paliogianni F; Yamada H; Balow JE; Boumpas DT J Immunol; 1993 Apr; 150(8 Pt 1):3109-18. PubMed ID: 8468460 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factors beta slow down cell-cycle progression in a murine interleukin-2 dependent T-cell line. Stoeck M; Miescher S; MacDonald HR; Von Fliedner V J Cell Physiol; 1989 Oct; 141(1):65-73. PubMed ID: 2789227 [TBL] [Abstract][Full Text] [Related]
4. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression. Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783 [TBL] [Abstract][Full Text] [Related]
5. Co-stimulation of T cell proliferation by transforming growth factor-beta 1. Lee HM; Rich S J Immunol; 1991 Aug; 147(4):1127-33. PubMed ID: 1831218 [TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes. Inge TH; McCoy KM; Susskind BM; Barrett SK; Zhao G; Bear HD J Immunol; 1992 Jun; 148(12):3847-56. PubMed ID: 1602133 [TBL] [Abstract][Full Text] [Related]
7. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells. Kasid A; Bell GI; Director EP J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414 [TBL] [Abstract][Full Text] [Related]
8. Evidence that TGF-beta can inhibit human T-lymphocyte proliferation through paracrine and autocrine mechanisms. Fox FE; Ford HC; Douglas R; Cherian S; Nowell PC Cell Immunol; 1993 Aug; 150(1):45-58. PubMed ID: 8393732 [TBL] [Abstract][Full Text] [Related]
9. Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transduction. Ortaldo JR; Mason AT; O'Shea JJ; Smyth MJ; Falk LA; Kennedy IC; Longo DL; Ruscetti FW J Immunol; 1991 Jun; 146(11):3791-8. PubMed ID: 1851793 [TBL] [Abstract][Full Text] [Related]
10. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction. Tao X; Davis LS; Hashimoto K; Lipsky PE J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the immunosuppressive properties of milk growth factor and transforming growth factors beta 1 and beta 2. Stoeck M; Ruegg C; Miescher S; Carrel S; Cox D; Von Fliedner V; Alkan S J Immunol; 1989 Nov; 143(10):3258-65. PubMed ID: 2530275 [TBL] [Abstract][Full Text] [Related]
12. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta. Smyth MJ; Strobl SL; Young HA; Ortaldo JR; Ochoa AC J Immunol; 1991 May; 146(10):3289-97. PubMed ID: 1827481 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor type beta 1 (TGF-beta 1) down-regulates interleukin-2 production and up-regulates interleukin-2 receptor expression in a thymoma cell line. D'Angeac AD; Dornand J; Emonds-Alt X; Jullien P; Garcia-Sanz JA; Erard F J Cell Physiol; 1991 Jun; 147(3):460-9. PubMed ID: 2066366 [TBL] [Abstract][Full Text] [Related]
14. IL-1 alpha induces expression of active transforming growth factor-beta in nonproliferating T cells via a post-transcriptional mechanism. Bristol LA; Ruscetti FW; Brody DT; Durum SK J Immunol; 1990 Dec; 145(12):4108-14. PubMed ID: 2175324 [TBL] [Abstract][Full Text] [Related]
15. Promotion of human T lymphocyte proliferation by IL-4. Mitchell LC; Davis LS; Lipsky PE J Immunol; 1989 Mar; 142(5):1548-57. PubMed ID: 2783946 [TBL] [Abstract][Full Text] [Related]
16. Suppressor T cell-activating macrophages in ultraviolet-irradiated human skin induce a novel, TGF-beta-dependent form of T cell activation characterized by deficient IL-2r alpha expression. Stevens SR; Shibaki A; Meunier L; Cooper KD J Immunol; 1995 Dec; 155(12):5601-7. PubMed ID: 7499843 [TBL] [Abstract][Full Text] [Related]
17. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A. Foxwell BM; Simon J; Herrero JJ; Taylor D; Woerly G; Cantrell D; Ryffel B Immunology; 1990 Jan; 69(1):104-9. PubMed ID: 2312149 [TBL] [Abstract][Full Text] [Related]
18. Comparison of phorbol ester/calcium ionophore and phytohemagglutinin-induced signaling in human T lymphocytes. Demonstration of interleukin 2-independent transferrin receptor gene expression. Kumagai N; Benedict SH; Mills GB; Gelfand EW J Immunol; 1988 Jan; 140(1):37-43. PubMed ID: 3121740 [TBL] [Abstract][Full Text] [Related]
19. CD28 co-stimulation regulates the effect of transforming growth factor-beta1 on the proliferation of naïve CD4+ T cells. Sung JL; Lin JT; Gorham JD Int Immunopharmacol; 2003 Feb; 3(2):233-45. PubMed ID: 12586604 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying T-lymphocyte activation: mitogen initiates and IL-2 amplifies the expression of transferrin receptors via intracellular iron level. Pelosi-Testa E; Samoggia P; Giannella G; Montesoro E; Caravita T; Salvo G; Camagna A; Isacchi G; Testa U; Peschle C Immunology; 1988 Jun; 64(2):273-9. PubMed ID: 3134296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]